The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anaemic patients with chronic kidney disease not on renal replacement therapy.
Official Title
Open Randomized Phase IV Study on Intravenous Iron in Anemic Patients With Chronic Kidney Disease.
Conditions
- Chronic Kidney Failure
Study Type
Interventional
Study Design
Treatment, Randomised, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study.
Further Details
Study Start
March 2004
Eligibility & Criteria
- Ages Eligible for Study: 18 years and older
-
Genders Eligible for Study:
Both
Inclusion Criteria:
-
Chronic kidney disease
-
Anaemia (Hb 8 – 11.5 g/dl)
-
Age above 18 years
-
Signed informed consent
Exclusion Criteria:
-
Rapid progression of kidney disease
-
Need for dialysis
-
Uncontrolled hypertension
Total Enrolment
50
Contact Details
Roland M Schaefer, MD
University Hospital Muenster
Location:
Westphalia University Hospital Muenster
Muenster, Westphalia,
Germany, 48149
All content and media on the HealthEngine Blog is created and published online for informational purposes only. It is not intended to be a substitute for professional medical advice and should not be relied on as health or personal advice. Always seek the guidance of your doctor or other qualified health professional with any questions you may have regarding your health or a medical condition. Never disregard the advice of a medical professional, or delay in seeking it because of something you have read on this Website. If you think you may have a medical emergency, call your doctor, go to the nearest hospital emergency department, or call the emergency services immediately.